Estimates computed as weighted proportions/means, considering sample design. Multivariate logistic regression models to evaluate the association of diabetes and LEF; and predictors of LEF in diabetics. Results: 7675 subjects were analysed, of which 1173 reported diabetes. Diabetics were older (mean age 66.0 ± 11.49y), more frequently reported osteoporosis and falls in the previous 12 months (32.4% vs. 22.9%). Prevalence of self-reported LEF was 16.2% (95% CI:13.68-19.13) among diabetics (vs. 13.3%, 95% CI:12.14-14.57, in nondiabetics); OR for the association diabetes and LEF:1.26, 95% CI:1.01-1.58, p = 0.045 (in women, adjusted OR:1.41, 95% CI:1.05-1.89, p = 0.02). Thirty percent of diabetics reported at least one major LEF and 70% in other sites. In diabetics, LEF was independently associated with self-reported osteoporosis and falls in the previous 12 months. Conclusion: People with diabetes reported more falls and had higher prevalence of selfreported LEF. Self-reported osteoporosis and falls were associated with LEF in diabetics.Our findings emphasize the need for fracture and falls preventive measures in diabetics.
Introdução: O hematoma do recto abdominal é uma entidade rara e causa incomum de dor abdominal. Apesar de habitualmente benigno, é potencialmente fatal, sobretudo em doentes idosos e hipocoagulados. Pretendemos estudar a ocorrência e apresentação clínica desta entidade, focando a sua relação com a terapêutica hipocoagulante.
Material e Métodos: Análise retrospetiva de uma série de casos observados num serviço de Medicina de um hospital terciário universitário e revisão da literatura. Foram incluídos doentes com diagnóstico de hematoma do recto abdominal de 2010 a 2018.
Resultados: No período de estudo foram identificados 9 casos em 14 730 admissões, com idade média de 78 ± 9 anos, 6 do sexo feminino. Todos apresentaram hematoma do recto abdominal espontâneo. Quarenta e quatro por cento foram graves, segundo a classificação de Berná e a mortalidade foi de 11%. A apresentação mais frequente foi dor abdominal com queda de hemoglobina (média de 3,7 ± 1,8 g/ dL) e confirmou-se o diagnóstico por tomografia computorizada. Todos os doentes estavam hipocoagulados. Os doentes sob dicumarínicos apresentaram INR supra-terapêutico (média 6,0 ± 2,6) e um factor precipitante (tosse), ao contrário dos doentes sob heparina de baixo peso molecular. Foi necessário reverter a anticoagulação em 6 casos. Cinco doentes tiveram alta hipocoagulados, sem recorrência de hematoma do recto abdominal.
Discussão/Conclusão: O hematoma do recto abdominal deve ser considerado no diagnóstico diferencial de dor abdominal em doentes anticoagulados. Apesar de ser uma complicação rara da terapêutica hipocoagulante, pode resultar num desfecho fatal. A administração correcta da heparina de baixo peso molecular, o controlo rigoroso do INR e a elevada suspeita clínica poderão contribuir para uma menor morbi-mortalidade.
Tuberculosis of the breast is an uncommon disease. The authors present a case of an asymptomatic 64 year-old patient whose mammography showed a right breast nodule which needed aetiological investigation. Complementary diagnostic exams did not lead to a differential diagnosis between granulomatous lesion and breast carcinoma; nodule aspiration results suggested tuberculosis of the breast but were unclear and so tuberculosis antibiotics were initiated. No other tuberculosis infectious focus was found at clinical- laboratory evaluation. Imagiology progress was favourable, so patient continued treatment. The authors highlight the low rate of primary tuberculosis of the breast and make a brief reference to the pathology, which has a low rate of microbiological and pathological- anatomical identification.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.